Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care
This article was originally published in Start Up
Executive Summary
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.
You may also be interested in...
Advanced Wound Care: A Future Built On Innovation
The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.
Start-Ups, Strategics Help Mend Wound Repair
Large numbers of patients with chronic wounds haven’t responded to existing treatments, and their open wounds can have dire consequences. The suffering of patients, the failures of past remedy attempts, and new financial pressures on hospitals have medtech entrepreneurs and venture investors focused on finding better solutions to wound care.
Start-Up News
"Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care" features profiles of Repaplix and Spiracur. This article was excerpted from the July issue of Start-Up magazine.